Listed

Vita Coco Company, Inc.: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 5, 2023 and accepted by EDGAR at May 5, 2023, 16:14 ET.

Share

Management's discussion and analysis

As filed, 34,021 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as our audited consolidated financial statements and related notes as disclosed in our Annual Report on Form 10-K, for the fiscal year ended December 31, 2022 and filed with the Securities and Exchange Commission ("SEC") on March 14,2023 (the “Form 10-K”). This discussion contains forward-looking statements based upon current plans, expectations and beliefs involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in Part I, Item 1A, “Risk Factors” and other factors set forth in the Form 10-K and this Quarterly Report on Form 10-Q.

Overview

The Vita Coco Company is a leading platform for brands in the functional beverage category. We pioneered packaged coconut water in 2004 and have extended our business into other healthy hydration categories. Our mission is to deliver great tasting, natural and nutritious products that we believe are better for consumers and better for the world. We are one of the largest brands globally in the coconut and other plant waters category, and one of the largest suppliers of Private Label coconut water.

Our branded portfolio is led by our Vita Coco brand, which is the leader in the coconut water category in the United States, and also includes coconut oil, juice, hydration mix and milk offerings. Our other brands include Runa, a plant-based energy drink inspired from the guayusa plant native to Ecuador, Ever & Ever, a sustainably packaged water, and PWR LIFT, a protein-infused fitness drink. We also supply Private Label products to key retailers in both the coconut water and coconut oil categories. We also conduct other revenue transactions such as bulk product sales to beverage and food companies.

We source our coconut water from a diversified global network of 14 factories across six countries supported by thousands of coconut farmers. As we do not own any of these factories, our supply chain is a fixed asset-lite model designed to better react to changes in the market or consumer preferences. We also work with co-packers in America and Europe to support local packaging and repacking of our products to better service our customers’ needs.

Vita Coco is available in over 30 countries, with our primary markets in North America, the United Kingdom, and China. Our primary markets for Private Label are North America and Europe. Our products are distributed primarily through club, food, drug, mass, convenience, e-commerce, and foodservice channels. We are also available in a variety of on-premise locations such as corporate offices, fitness clubs, airports, and educational institutions.

Key Factors Affecting Our Performance

We believe that our performance and future success depend on a number of factors that present significant opportunities for us. There have been no material changes to such factors from those described in the Form 10-K under the heading “Key Factors Affecting our Performance” other than the changes noted below in "Impact of COVID-19 and the Current Geopolitical and Economic Instability." Those factors also pose risks and challenges, including those discussed in Part I, Item 1A. “Risk Factors” of the Form 10-K.

Impact of COVID-19 and the Current Geopolitical and Economic Instability

Disruptions in the worldwide economy may affect our business, and the macroeconomic environment continues to be affected by the impacts of the COVID-19 pandemic and the current geopolitical and economic instability (including the effects of the conflict between Ukraine and Russia). As a result, in the years ended December 31, 2022 and 2021, the Company saw significant cost inflation to domestic and international shipping costs and some inflationary pressures on other cost elements, which have been partially covered by pricing actions to date. For the three months ended March 31, 2023, we saw more favorable transportation costs than the same period in the prior year as the supply chain environment stabilizes, but general inflationary pressures continue to increase the other elements of our cost of goods and operating expenses. The Company is continuing to monitor the situation carefully to understand any future potential impact on its people and business, including but not limited to rising inflation rates, and actions taken by both U.S. and foreign governments to control such increases. The Company has also seen greater volatility on foreign exchange rates. A strong dollar generally benefits the Company's supply chain activities while negatively impacting our reported international revenues.

As a result, it is not currently possible to ascertain the overall impact of COVID-19 or the ongoing economic and geopolitical instability on the Company’s business, results of operations, financial condition, or liquidity. Future events and effects related to COVID-19 or the on-going geopolitical and economic instability cannot be determined with precision and actual results could significantly differ from estimates or forecasts. For a further discussion of the risks and challenges posed by these events, please see Part I, Item 1A. “Risk Factors” in our Form 10-K.

Components of Our Results of Operations

Net Sales

We generate revenue through the sale of our Vita Coco branded coconut water, Private Label and Other products in the Americas and International segments. Our sales are predominantly made to distributors or to retailers for final sale to consumers through retail channels, which includes sales to traditional brick and mortar retailers, who may also resell our products through their own online platforms. Our revenue is recognized net of allowances for returns, discounts, credits, and any taxes collected from consumers.

Cost of Goods Sold

Cost of goods sold includes the costs of the products sold to customers, inbound and outbound shipping and handling costs, freight and duties, shipping and packaging supplies, and warehouse fulfillment costs.

Gross Profit and Gross Margin

Gross profit is net sales less cost of goods sold, and gross margin is gross profit as a percentage of net sales. Gross profit has been, and will continue to be, affected by various factors, including the mix of products we sell, the channels through which we sell our products, the promotional environment in the marketplace, manufacturing costs, commodity prices, warehouse costs, and transportation rates. We expect that our gross margin will fluctuate from period to period depending on the interplay of these variables.

Management believes gross margin provides investors with useful information related to the profitability of our business prior to considering the operating costs incurred. Management uses gross profit and gross margin as key measures in making financial, operating, and planning decisions and in evaluating our performance.

Operating Expenses

Selling, General and Administrative Expenses

Selling, general and administrative expenses ("SG&A") include marketing expenses, sales promotion expenses, and general and administrative expenses. Marketing and sales promotion expenses consist primarily of costs incurred promoting and marketing our products and are primarily driven by investments to grow our business and retain customers. We expect SG&A to increase in absolute dollars and to vary from period to period as a percentage of net sales for the foreseeable future. General and administrative expenses include payroll, employee benefits, stock-based compensation, broker commissions and other headcount-related expenses associated with supply chain & operations, finance, information technology, human resources and other administrative-related personnel, as well as general overhead costs of the business, including research and development for new innovations, rent and related facilities and maintenance costs, depreciation and amortization, and legal, accounting, and professional fees. We expense all SG&A as incurred.

Other Income (Expense), Net

Unrealized Gain/(Loss) on Derivative Instruments

We are subject to foreign currency risks as a result of our inventory purchases and intercompany transactions. In order to mitigate the foreign currency risks, we and our subsidiaries enter into foreign currency exchange contracts which are recorded at fair value. Unrealized gain on derivative instruments consists of gains or losses on such foreign currency exchange contracts which are unsettled as of period end. See Part I, Item 3 “Quantitative and Qualitative Disclosures about Market Risk—Foreign Currency Exchange Risk” for further information.

Foreign Currency Gain/(Loss)

Our reporting currency is the U.S. dollar. We maintain the financial statements of each entity within the group in its local currency, which is also the entity’s functional currency. Foreign currency gain/(loss) represents the transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency. See “—Quantitative and Qualitative Disclosures about Market Risk—Foreign Currency Exchange Risk” for further information.

Interest Income

Interest income consists of interest income earned on our cash and cash equivalents, and money market funds.

Interest Expense

Interest expense consists of interest payable on our credit facilities and vehicle loans.

Income Tax Expense

We are subject to federal and state income taxes in the United States and taxes in foreign jurisdictions in which we operate. We recognize deferred tax assets and liabilities based on temporary differences between the financial reporting and income tax bases of assets and liabilities using statutory rates. We regularly assess the need to record a valuation allowance against net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

Operating Segments

We operate in two reporting segments:

  • ***Americas—***The Americas segment is comprised of our operations in the Americas region, primarily in the United States and Canada.
  • ***International—***The International segment is comprised of our operations primarily in Europe, the Middle East, and the Asia Pacific regions.

Each segment derives its revenues from the following product categories:

  • ***Vita Coco Coconut Water—***This product category consists of all branded coconut water product offerings under the Vita Coco labels, where the majority ingredient is coconut water. For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue.
  • ***Private Label —***This product category consists of all private label product offerings, which includes coconut water and oil. The Company determined the production and distribution of private label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these private label products over time as the production for open purchase orders occurs, which may be prior to any shipment.
  • ***Other—***This product category consists of all other products, which includes Runa, Ever & Ever and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, coconut milk products, and other revenue transactions (e.g., bulk product sales). For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue.

Results of Operations

Comparison of the Three Months Ended March 31, 2023 and 2022

The following table summarizes our results of operations for the three months ended March 31, 2023 and 2022, respectively:

(in thousands)

2023 Three Months Ended March 31, 2022
Net sales $109,759 $96,448
Cost of goods sold 76,098 77,385
Gross profit 33,661 19,063
Operating expenses
Selling, general, and administrative 26,957 24,801
Income (loss) from operations 6,704 (5,738)
Other income (expense)
Unrealized gain/(loss) on derivative instrument 1,213 8,706
Foreign currency gain/(loss) 611 (101)
Interest income 13 7
Interest expense (15) (27)
Total other income (expense) 1,822 8,585
Income before income taxes 8,526 2,847
Income tax expense (1,821) (620)
Net income $6,705 $2,227

Net Sales

The following table provides a comparative summary of net sales by operating segment and product category:

(in thousands)

2023 Americas segment Three Months Ended March 31, 2022 Amount Change Percentage
Vita Coco Coconut Water $69,138 $58,855 $10,283 17.5%
Private Label 25,050 23,080 1,971 8.5%
Other 2,584 2,676 (92) -3.5%
Subtotal 96,772 84,611 12,161 14.4%
International segment
Vita Coco Coconut Water 9,558 8,349 $1,209 14.5%
Private Label 2,666 2,765 (99) (3.6)%
Other 763 723 40 5.5%
Subtotal $12,987 $11,837 $1,150 9.7%
Total net sales $109,759 $96,448 $13,311 13.8%

For the three months ended March 31, 2023, the primary driver of the consolidated net sales increase of 14% was increased case equivalents ("CE") volume growth of 8.3% coupled with some benefits from net pricing actions.

Volume in Case Equivalent

The following table provides a comparative summary of our volume in CE, by operating segment and product category:

(in thousands)

2023 Americas segment Three Months Ended March 31, 2022 Amount Change Percentage
Vita Coco Coconut Water 7,221 6,295 926 14.7%
Private Label 2,660 2,730 (70) (2.6)%
Other 239 366 (127) (34.7)%
Subtotal 10,120 9,391 729 7.8%
International segment*
Vita Coco Coconut Water 1,400 1,206 194 16.1%
Private Label 394 413 (19) (4.6)%
Other 20 13 7 53.6%
Subtotal 1,814 1,632 182 11.2%
Total volume (CE) 11,934 11,023 911 8.3%

Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil.

* International Other excludes minor volume that is treated as zero CE.

Americas Segment

Americas net sales increased by $12.2 million, or 14.4%, to $96.8 million for the three months ended March 31, 2023 from $84.6 million for the three months ended March 31, 2022. The increase is primarily driven by a CE volume increase of 7.8% and benefits from pricing actions and mix changes contributing 6.1% growth.

Vita Coco Coconut Water net sales increased by $10.3 million, or 17.5%, to $69.1 million for the three months ended March 31, 2023, from $58.9 million for the three months ended March 31, 2022. The increase was primarily driven by CE volume growth of 14.7%, with pricing actions and mix changes contributing 2.4% growth.

Private Label net sales increased $2.0 million, or 8.5%, to $25.1 million for the three months ended March 31, 2023, from $23.1 million for the three months ended March 31, 2022. As Private Label volume declined 2.6%, the net sales increase is mostly attributable to pricing and mix impacts across coconut water and coconut oil.

Net sales for Other products decreased by $0.1 million, or 3.5%, to $2.6 million for the three months ended March 31, 2023 from $2.7 million for the three months ended March 31, 2022, primarily due to a slight volume decline.

International Segment

International net sales increased by $1.2 million, or 9.7%, to $13.0 million for the three months ended March 31, 2023, from $11.8 million for the three months ended March 31, 2022. The increase is primarily driven by higher CE volume across all international markets with volume growth of 11.2%.

Vita Coco Coconut Water net sales increased by $1.2 million, or 14.5%, to $9.6 million for the three months ended March 31, 2023, from $8.3 million for the three months ended March 31, 2022. The increase was driven by CE volume growth of 16.1%, primarily in the European region, which was partially offset by an unfavorable impact related to foreign currency.

Decreases in net sales from Private Label of $0.1 million were largely driven by a decline in CE volume of 4.6% for the three months ended March 31, 2023 compared to March 31, 2022.

Net sales from Other products was relatively flat on a dollar basis for the three months ended March 31, 2023 compared to March 31, 2022.

Gross Profit

(in thousands)

2023 Cost of goods sold Three Months Ended March 31, 2022 Amount Change Percentage
Americas segment 67,622 68,315 $(693) (1.0)%
International segment 8,476 9,070 (594) (6.5)%
Total cost of goods sold $76,098 $77,385 $(1,287) (1.7)%
Gross profit
Americas segment 29,150 16,296 $12,854 78.9%
International segment 4,511 2,767 1,744 63.0%
Total gross profit $33,661 $19,063 $14,598 76.6%
Gross margin
Americas segment 30.1% 19.3% 10.8%
International segment 34.7% 23.4% 11.3%
Consolidated 30.7% 19.8% 10.9%

On a consolidated basis, cost of goods sold decreased $1.3 million, or 1.7%, to $76.1 million for the three months ended March 31, 2023, from $77.4 million for the three months ended March 31, 2022. On a consolidated and segment basis, the decrease was driven by a reduction in transportation rates across ocean freight and domestic logistics, as we saw a stabilization of our supply chain, offset partially by increased volume. On a consolidated basis, this resulted in cost of goods per CE rate decreasing 10% for the three months ended March 31, 2023 as compared to the prior year period.

On a consolidated basis, gross profit increased $14.6 million, or 76.6%, to $33.7 million for the three months ended March 31, 2023, from $19.1 million for the three months ended March 31, 2022. This was the result of strong top line growth along with decreasing transportation costs. As a result, gross margin increased approximately 11 percentage points to 30.7% for the three months ended March 31, 2023, as compared to 19.8% for the three months ended March 31, 2022.

Operating Expenses

(in thousands)

2023 Three Months Ended March 31, 2022 Amount Change Percentage
Selling, general, and administrative $26,957 $24,801 $2,156 8.7%

Selling, General and Administrative Expenses

During the three months ended March 31, 2023, SG&A increased by $2.2 million, or 8.7% versus the prior year comparable period. The increase was primarily driven by an increase of $1.2 million in personnel related expenses for the three months ended March 31, 2023 versus the prior year comparable period and $0.8 million increase related to the change in the methodology to estimate current expected credit losses related to the adoption of the accounting guidance in ASU 2016-13 on January 1, 2023 as discussed in Note 2, Summary of Significant Accounting Policies, to our condensed consolidated financial statements included in this Form 10-Q .

Other Income (Expense), Net

(in thousands)

2023 Three Months Ended March 31, 2022 Amount Change Percentage
Unrealized gain/(loss) on derivative instruments $1,213 $8,706 $(7,493) 86.1%
Foreign currency gain/(loss) 611 (101) 712 705.0%
Interest income 13 7 6 85.7%
Interest expense (15) (27) 12 44.4%
$1,822 $8,585 $(6,763) 78.8%

Unrealized Gain/(Loss) on Derivative Instruments

During the three months ended March 31, 2023 and 2022, we recorded gains of $1.2 million and $8.7 million, respectively, for the mark-to-market changes in fair value on the outstanding derivative instruments for forward foreign currency exchange contracts, with the largest gain for the three months ended March 31, 2023 related to the contracts hedging the Brazilian real. All forward foreign currency exchange contracts were entered into to hedge some of our exposures to the British pound, Canadian dollar, Brazilian real, Malaysian ringgit, and Thai baht.

Foreign Currency Gain/(Loss)

Foreign currency gain was $0.6 million for the three months ended March 31, 2023, as compared to a $0.1 million loss for the three months ended March 31, 2022. The change in both periods was a result of movements in various foreign currency exchange rates related to transactions denominated in currencies other than the functional currency.

Interest Income

The increase in interest income for the three months ended March 31, 2023 compared to the same period in the prior year was immaterial.

Interest Expense

Interest expense decreased an immaterial amount for the three months ended March 31, 2023 compared to the same period in the prior year.

Income Tax Expense

(in thousands)

2023 Three Months Ended March 31, 2022 Amount Change Percentage
Income tax expense (1,821) (620) $(1,201) (193.7)%
Tax rate 21.4% 21.8%

Our quarterly income tax provision is based on an estimated annual effective tax rate applied to our consolidated year-to-date pre-tax income or loss. The effective income tax rate is based upon the estimated income for the year, the composition of that income in different countries, and adjustments, if any, in the applicable quarterly periods for the potential tax consequences, benefits, resolutions of tax audits or other tax contingencies.

For the three months ended March 31, 2023, and March 31, 2022, our effective tax rate was 21.4% and 21.8%, respectively. The effective tax rate for both periods is higher than the U.S. statutory rate of 21% primarily as a result of state income taxes for the U.S. company and other nondeductible expenses for tax purposes, and is partially offset by lower statutory tax rates in countries outside the U.S. that the Company operates in. The change in effective tax rates between the periods is primarily driven by the relative impact of other non-deductible expense in relation to the pre-tax profits.

Non-GAAP Financial Measures

EBITDA and Adjusted EBITDA are supplemental non-GAAP financial measures that are used by management and external users of our financial statements, such as industry analysts, investors, and lenders. These non-GAAP measures should not be considered as alternatives to net income as a measure of financial performance or cash flows from operations as a measure of liquidity, or any other performance measure derived in accordance with GAAP and should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

These non-GAAP measures are a key metric used by management and our Board of Directors, to assess our financial performance. We present these non-GAAP measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company.

We define EBITDA as net income before interest, taxes, depreciation, and amortization. Adjusted EBITDA is defined as EBITDA with adjustments to eliminate the impact of certain items, including certain non-cash and other items, that we do not consider representative of our ongoing operating performance.

A reconciliation from net income to EBITDA and Adjusted EBITDA is set forth below:

(in thousands)

Three Months Ended March 31, 2023 2022
Net income 6,705 2,227
Depreciation and amortization 165 470
Interest income (13) (7)
Interest expense 15 27
Income tax expense 1,821 620
EBITDA 8,693 3,337
Stock-based compensation (a) 2,162 2,386
Unrealized (gain)/loss on derivative instruments (b) (1,213) (8,706)
Foreign currency (gain)/loss (b) (611) 101
Adjusted EBITDA $9,031 $(2,882)

(a) Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards. We adjusted for these charges to facilitate comparison from period to period.

(b) Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance.

Liquidity and Capital Resources

Since our inception, we have financed our operations primarily through cash generated from our business operations and proceeds on borrowings through our credit facilities and term loans. We had $29.1 million and $19.6 million of cash and cash equivalents as of March 31, 2023 and December 31, 2022, respectively. From time to time, we supplement our liquidity needs with incremental borrowing capacity under the 2020 Credit Facility.

Considering recent market conditions and the continued impacts of the ongoing COVID-19 pandemic and geopolitical and economic instability, we have reevaluated our operating cash flows and cash requirements and believe that current cash, cash equivalents, future cash flows from operating activities and cash available under our 2020 Credit Facility will be sufficient to meet our anticipated cash needs, including working capital needs, capital expenditures, and contractual obligations for at least 12 months from the issuance date of the condensed consolidated financial statements included herein and the foreseeable future.

Our future capital requirements will depend on many factors, including our revenue growth rate, our working capital needs primarily for inventory build, our global footprint, the expansion of our marketing activities, the timing and extent of spending to support product development efforts, the introduction of new and enhanced products and the continued market consumption of our products, as well as any shareholder distribution either through equity buybacks or dividends. Our asset-lite operating model has historically provided us with a low cost nimble, and scalable supply chain, which allows us to adapt to changes in the market or consumer preferences while also efficiently introducing new products across our platform. We may seek additional equity or debt financing in the future in order to acquire or invest in complementary businesses, products and/or new IT infrastructures. In the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all. If we are unable to raise additional capital or general cash flows necessary to expand our operations and invest in continued product innovation, we may not be able to compete successfully, which would harm our business, operations and financial condition.

Cash Flows

The following tables summarize our sources and uses of cash:

(in thousands)

Cash flows provided by (used in): Three Months Ended March 31, 2023 2022 Change Amount Percentage
Operating activities $9,436 $(22,548) $31,984 141.8%
Investing activities (449) (244) (205) (84.0%)
Financing activities 597 12,144 (11,547) 95.1%
Effects of exchange rate changes on cash and cash equivalents 187 (56) 243 n/m
Net (decrease)/increase in cash and cash equivalents and restricted cash $9,771 $(10,704) $20,475 191.3%

n/m—represents percentage calculated not being meaningful

Operating Activities

Our main source of operating cash is payments received from our customers. Our primary use of cash in operating activities are for cost of goods sold and SG&A expenses.

During the three months ended March 31, 2023, $32.0 million more cash was generated in operating activities compared to the three months ended March 31, 2022. The higher cash inflow from operating activities was primarily driven by higher net income, reflecting higher volume, benefits of prior year pricing actions and lower transportation costs, as well as a slight improvement in working capital.

Investing Activities

During the three months ended March 31, 2023 as compared to three months ended March 31, 2022, cash used in investing activities increased driven by cash paid for property and equipment.

Financing Activities

During the three months ended March 31, 2023 compared to the three months ended March 31, 2022, net cash provided by financing activities decreased $12 million, primarily driven by a reduction in borrowings as there were no borrowings under the 2020 Credit Facility during the three months ended March 31, 2023 compared to $12 million borrowed during the same period in the prior year.

Debt

We had debt outstanding of $0.1 million as of March 31, 2023 and December 31, 2022. The outstanding balance as of March 31, 2023 and December 31, 2022 was related to vehicle loans.

2020 Credit Facility

The 2020 Credit Facility currently provides for committed borrowings of $60.0 million. We may repay outstanding balances under the 2020 Credit Facility at any time without premium or penalty. In December 2022, the Company amended the 2020 Credit Facility to transition the interest rate from reference to LIBOR to SOFR. Borrowings on the 2020 Credit Facility bear interest at rates based on either: 1) a fluctuating rate per annum determined to be the sum of Daily Simple SOFR plus a spread defined in the credit agreement (the "Spread") or 2) a fixed rate per annum determined to be the sum of the Term SOFR plus the Spread. The Spread ranges from 1.00% to 1.75%, which is based on the Company’s leverage ratio (as defined in the credit agreement) for the immediately preceding fiscal quarter as defined in the credit agreement. In addition, the Company is currently subject to an unused commitment fee ranging from 0.10% and 0.20% on the unused amount of the line of credit, with the rate being based on the Company’s leverage ratio (as defined in the credit agreement). The maturity date on the 2020 Credit Facility is May 12, 2026.

The borrowings made before the December 2022 amendment bore interest at rates based on either: 1) LIBOR or 2) a specified base rate (determined by reference to the greatest of the prime rate published by Wells Fargo, the federal funds effective rate plus 1.5% and one-month LIBOR plus 1.5%), as selected periodically by the Company. The LIBOR-based loans bore interest at LIBOR plus the Spread. The unused commitment fee prior to amendment was the same.

The outstanding balance on the 2020 Credit Facility was zero as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023, we were compliant with all financial covenants.

Vehicle Loans

We periodically enter into vehicle loans. Interest rates on these vehicle loans range from 4.56% to 5.68%. The outstanding balance on the vehicle loans as of March 31, 2023 was less than $0.1 million.

For additional information, see Note 6, Debt, to our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Contractual Obligations and Commitments

There have been no material changes to our contractual obligations from those described in the Form 10-K.

Critical Accounting Policies and Significant Judgments and Estimates

Our consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.

Our critical accounting policies are described under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Significant Judgments and Estimates” in the Form 10-K and the notes to the unaudited condensed consolidated financial statements appearing in this Quarterly Report on Form 10-Q. During the three months ended March 31, 2023, there were no material changes to our critical accounting policies from those discussed in the Form 10-K.

Recent Accounting Pronouncements

A description of recently adopted and issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2, Summary of Significant Accounting Policies, to our condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q. We adopted ASC 842, ASU 2016-13 as described in Note 2, as of January 1, 2023.

Market risk

As filed, 3,819 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Interest Rate Risk

We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities.

As of March 31, 2023 and December 31, 2022 , the outstanding amounts related to our 2020 Credit Facility incur interest fees at variable interest rates and are affected by changes in the general level of market interest rates. However, there was zero outstanding balance on the 2020 Credit Facility as of March 31, 2023 and December 31, 2022.

Foreign Currency Exchange Risk

We transact business globally in multiple currencies and hence have foreign currency risks related to our net sales, cost of goods sold and operating expenses. We use derivative financial instruments to reduce our net exposure to foreign currency fluctuations. Our objective in managing exposure to foreign currency fluctuations is to reduce the volatility caused by foreign exchange rate changes on the earnings, cash flows, and financial position of our international operations. We generally target to hedge a majority of our forecasted yearly foreign currency exchange exposure through a 24-month rolling layered approach and leave a portion of our currency forecast floating at spot rate. Our currency forecast and hedge positions are reviewed quarterly. The gains and losses on the forward contracts associated with our balance sheet positions are recorded in ‘‘Other income (expense), net” in the condensed consolidated statements of operations.

The total notional values of our forward exchange contracts were $106.6 million and $97.4 million as of March 31, 2023 and December 31, 2022, respectively. The derivatives on the forward exchange contracts resulted in an unrealized gain of $1.2 million for the three months ended March 31, 2023, and we estimate that a 10 percent strengthening or weakening of the U.S. dollar would have resulted in an approximately $6.7 million gain or loss, respectively.

A portion of our cash and cash equivalents are denominated in foreign currencies. As of March 31, 2023, a 1% change in the value of the U.S. dollar compared to foreign currencies would have caused our cash and cash equivalents to decrease or increase by $0.1 million. As of December 31, 2022, a 1% change in the value of the U.S. dollar compared to foreign currencies would have caused our cash and cash equivalents to decrease or increase by $0.1 million.

Inflation Risk

Inflation generally affects us by increasing our cost of transportation, labor and manufacturing costs. We have seen significant inflation on transportation costs compared to 2020 levels caused by COVID-19 related global supply chain disruptions and more general inflation effects which put pressure on our costs and margins related to economic and geopolitical instability. More specifically, we source a large amount of our finished goods from international countries, which exposes us to international supply chain inflation, particularly ocean freight. In the three months ended March 31, 2023, we have experienced a reduction in transportation rates from their recent peaks, but general inflationary pressures continue to increase the other elements of our cost of goods and operating expenses.

Credit Risk

We are exposed to concentration of credit risk from our major customers. In the three months ended March 31, 2023, sales to two customers represented approximately 50% of our consolidated net sales. We have not experienced credit issues with these customers. We maintain provisions for potential credit losses and evaluate the solvency of our customers on an ongoing basis to determine if additional allowances for doubtful accounts and customer credits need to be recorded. Significant economic disruptions or a slowdown in the economy could result in significant additional charges.

Controls and procedures

As filed, 1,520 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Limitations on effectiveness of controls and procedures

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Evaluation of disclosure controls and procedures

Our management, with the participation of our principal executive officer and principal financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2023, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 350 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Please refer to Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for a description of certain significant risks and uncertainties to which our business, financial condition and results of operations are subject. There have been no material changes to these risk factors as of March 31, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-01-01 to 2023-03-31$109.8mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2023-01-01 to 2023-03-31$76.1mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-01-01 to 2023-03-31$33.7mus-gaap:GrossProfit
Selling, general and administrative3 months2023-01-01 to 2023-03-31$27.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-01-01 to 2023-03-31$6.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-01-01 to 2023-03-31$15.0kus-gaap:InterestExpense
Income tax3 months2023-01-01 to 2023-03-31$1.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-01-01 to 2023-03-31$6.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-01-01 to 2023-03-31$0.12us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-01-01 to 2023-03-31$0.12us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-01-01 to 2023-03-3157,351,405 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2023-01-01 to 2023-03-31$9.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2023-01-01 to 2023-03-31$454.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2023-03-31$29.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$185.0mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$207.6mus-gaap:Assets
Current liabilitiesAt period end2023-03-31$55.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$57.9mus-gaap:Liabilities
Shareholders' equityAt period end2023-03-31$149.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001482981-23-000049. Last ingested by Listed: Nov 5, 2026, 16:46 ET. Listed shows no prices and gives no investment advice.